Current Pharmaceutical Design

Editor-in-Chief

Alessandro Antonelli
(12,288 citations)
Department of Clinical and Experimental Medicine
Laboratory of Primary Human Cells
University of Pisa
Pisa
(Italy)

Executive Editor

Atta-ur-Rahman, FRS
(32052 citations)
Honorary Life Fellow
Kings College
University of Cambridge
Cambridge
(UK)
Biography

Nobel Laureate on Editorial Board

Andrew V. Schally
(USA)

Personal Subscription
Become EABM
Become Reviewer
Call for Editor

Abstract Ahead of Print

Drug Targeting approaches and use of Drug Delivery systems in management of Cancer

Alka Ahuja*, Gurpreet K. Narde, Nida Mohammed Ali Wadi and Dhanalekshmi Unnikrishnan Meenakshi

Promises of Lipid-based Drug Delivery Systems in the Management of Breast Cancer

Nagarani Thotakura, Madan Mohan Gupta*, Jitendra Singh Rajawat and Kaisar Raza

Natural antibodies: Protecting role of IgM in glioblastoma and brain tumours

Shubham Semwal, Rabah Boukherroub, Savvas Savvides and Julie Bouckaert*

Female sexual dysfunction: a problem hidden in the shadows

Konstantinos P. Imprialos*, Konstantinos Koutsampasopoulos, Aleksandra Katsimardou, Sofia Bouloukou, Iakovos Theodoulidis, Mikos Themistoklis and Michael Doumas

Contraindications differ widely among Beta Blockers and Ought to be Cited for an Individual Drug, Not for the Entire Class

Goran Koraćević , Milovan Stojanović *, Tomislav Kostić , Dragan Lović, Marija Zdravković, Maja Koraćević, Dimitrije Pavlović and Slađana Mićić

The intracellular mechanism of Berberine-induced inhibition of CYP3A4 activity

Pan-Feng Feng, Long-Xun Zhu, Jing Jie, Peng-Xiang Yang and Xia Chen*

Synopsis on Pharmotechnological Approaches in Diagnostic to Management Strategies in Fighting Against COVID-19

Asim Azhar*, Nazia Hassan, Manvi Singh, Khaled Al-hosaini* and Mohammad Amjad Kamal*